PODCAST: Antitrust in a New Era — Competition Under the Trump Administration — C&M’s First 100 Days Series
Client Alert | 1 min read | 02.09.17
Cutting through the confusion surrounding the transition to the Trump Administration has been a challenge for businesses. As part of Crowell & Moring’s “First 100 Days” series, Antitrust Group partners Ryan Tisch, Joseph Miller, and Jeane Thomas discuss their predictions for what the transition will mean in the antitrust realm and how businesses should respond. Joe has worked in both the FTC and the DOJ’s Antitrust Division, and has experience with the transition process. Both Jeane and Ryan focus their practice on antitrust business counseling, merger control, and government investigations.
Covered in this 23 minute podcast:
- What factors might affect FTC and DOJ merger review.
- Predictions about the new administration's potential enforcement priorities.
- How businesses should position themselves for successful antitrust advocacy during this time of transition.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
